TSCAN THERAPEUTICS INC

Tscan Therapeutics (TCRX) is trading 3.65 percent higher on Friday 30th of October and has a trading volume of USD 71.5 k

Track Tscan Therapeutics (TCRX) stock: latest price, market cap, 52‑week highs/lows, and recent 24‑hour performance. Discover the company’s T‑cell therapy focus and market trends.

TSCAN THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Vanessa Liu

30/10/2026, 07:02

2 minutes to read

Tscan Therapeutics trades -6.4 percent lower on Wednesday 28th of October

Explore Tscan Therapeutics’ latest stock dip: 24‑hour trading down 6.4%, market cap $13.6 m, 52‑week high $2.14. Get insights on the biotech’s T‑cell therapy focus and market trends.

TSCAN THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

28/10/2026, 06:09

2 minutes to read